Paper41400007
Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.
Dori D and 5 others. Alzheimers Dement, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. Papers, record 41400007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41400007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Thyrotropin | Major topic |
| Thyroxine | Major topic |
| Cognitive Dysfunction | Major topic |
| Cognition | Major topic |
| Thyroid Gland | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Middle Aged | |
| Aged, 80 and over | |
| Thyroid Function Tests | |
| Canada | |
| Hypothyroidism | |
| Cohort Studies |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CNA-137794 | the Canadian Institutes of Health Research | PubMed | ||
| CNA-163902 | the Canadian Institutes of Health Research | PubMed | ||
| BDO-148341 | the Canadian Institutes of Health Research | PubMed |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16216938 | Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. | Arch Neurol | 2005 | https://conductscience.org/library/papers/16216938 | PubMed |
| 2 | 32222650 | Levothyroxine treatment is associated with an increased relative risk of overall and organ specific incident cancers - a cohort study of the Swedish population. | Cancer Epidemiol | 2020 | https://conductscience.org/library/papers/32222650 | PubMed |
| 3 | 30622468 | National Neuroinformatics Framework for Canadian Consortium on Neurodegeneration in Aging (CCNA). | Front Neuroinform | 2018 | https://conductscience.org/library/papers/30622468 | PubMed |
| 4 | 31309917 | The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort Study. | Can J Neurol Sci | 2019 | https://conductscience.org/library/papers/31309917 | PubMed |
| 5 | 34680464 | ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. | Biomedicines | 2021 | https://conductscience.org/library/papers/34680464 | PubMed |
| 6 | 17991805 | The clinical significance of subclinical thyroid dysfunction. | Endocr Rev | 2008 | https://conductscience.org/library/papers/17991805 | PubMed |
| 7 | 24100714 | Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study. | JAMA Intern Med | 2014 | https://conductscience.org/library/papers/24100714 | PubMed |
| 8 | 22891773 | EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. | Eur J Neurol | 2012 | https://conductscience.org/library/papers/22891773 | PubMed |
| 9 | 11425934 | Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. | Neurology | 2001 | https://conductscience.org/library/papers/11425934 | PubMed |
| 10 | 34491268 | Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis. | JAMA Intern Med | 2021 | https://conductscience.org/library/papers/34491268 | PubMed |
| 11 | 37807782 | Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37807782 | PubMed |
| 12 | 21527461 | Levothyroxine dose and risk of fractures in older adults: nested case-control study. | BMJ | 2011 | https://conductscience.org/library/papers/21527461 | PubMed |
| 13 | 25324467 | Reversal of cognitive decline: a novel therapeutic program. | Aging (Albany NY) | 2014 | https://conductscience.org/library/papers/25324467 | PubMed |
| 14 | 36675177 | Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36675177 | PubMed |
| 15 | 23246686 | Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. | Endocr Pract | 2012 | https://conductscience.org/library/papers/23246686 | PubMed |
| 16 | 34137866 | Thyroid Hormone Therapy and Incident Stroke. | J Clin Endocrinol Metab | 2021 | https://conductscience.org/library/papers/34137866 | PubMed |
| 17 | 11342678 | Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. | Neurology | 2001 | https://conductscience.org/library/papers/11342678 | PubMed |
| 18 | 32738937 | Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. | Lancet | 2020 | https://conductscience.org/library/papers/32738937 | PubMed |
| 19 | 36946455 | The Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis. | J Prev Alzheimers Dis | 2023 | https://conductscience.org/library/papers/36946455 | PubMed |
| 20 | 15817019 | The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. | J Am Geriatr Soc | 2005 | https://conductscience.org/library/papers/15817019 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42877439 | Higher thyroid-stimulating hormone level may delay dementia progression in patients without thyroid dysfunction. | J Alzheimers Dis Rep | 2026 | https://conductscience.org/library/papers/42877439 | PubMed |
| 42006950 | Global research trends on thyroid hormones and neurodegenerative diseases: a bibliometric study from 2015 to 2025. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42006950 | PubMed |
| 41400007 | Thyroid function and cognitive health: rethinking the relationship between "suboptimal" TSH/FT4 levels and cognitive decline. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41400007 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41400007
GET https://conductscience.org/api/papers/v1/41400007/references?page=2